Related Experiment Video
Updated: Dec 17, 2025
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
Haemophilus influenzae type b and pneumococcal conjugate vaccination coverage in children aged 2-59 months in Malawi
Daphne Gadama1, Tisungane Mvalo1,2, Amy Sarah Ginsburg3
1University of North Carolina Project Malawi , Lilongwe, Malawi.
Insights
Inadequate documentation of Haemophilus influenzae type b (Hib) and pneumococcal vaccines in Malawi hinders pneumonia research. Improving vaccination record-keeping is crucial for child health.
Area of Science:
- Pediatrics
- Vaccinology
- Infectious Diseases
Background:
- Childhood pneumonia remains a leading cause of mortality globally.
- High vaccination coverage with Haemophilus influenzae type b (Hib) and pneumococcal conjugate vaccines is essential for preventing severe pneumonia.
- Accurate vaccination records are vital for assessing vaccine impact and public health interventions.
Abstract:
High vaccination coverage with Haemophilus influenzae type b (Hib) and pneumococcal conjugate vaccines is critical to addressing childhood pneumonia's high mortality. The Innovative Treatments in Pneumonia project in Lilongwe, Malawi collected Hib and pneumococcal vaccination information from children's health passports and found the majority demonstrated inadequate and inconsistent documentation. We were unable to confidently assess the impact of Hib and pneumococcal vaccination on pneumonia treatment failure in our study population. Whether it be that enrolled children did not receive age-eligible vaccines or there was poor vaccination record-keeping, we do not know. A shift to an electronic data collection system may help ensure capture of essential vaccination data and provide more accurate records of both individual and population vaccination coverage in Malawi.
